Owens & Minor, Inc. (NYSE:OMI) is Coliseum Capital Management LLC's 9th Largest Position

Coliseum Capital Management LLC lifted its stake in Owens & Minor, Inc. (NYSE:OMI - Free Report) by 31.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,785,964 shares of the company's stock after acquiring an additional 1,141,483 shares during the period. Owens & Minor accounts for 5.2% of Coliseum Capital Management LLC's portfolio, making the stock its 9th largest position. Coliseum Capital Management LLC owned 6.21% of Owens & Minor worth $62,553,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Inspire Advisors LLC grew its holdings in Owens & Minor by 11.2% in the fourth quarter. Inspire Advisors LLC now owns 15,350 shares of the company's stock worth $201,000 after purchasing an additional 1,548 shares during the last quarter. Blue Trust Inc. grew its stake in Owens & Minor by 57.4% during the 4th quarter. Blue Trust Inc. now owns 4,387 shares of the company's stock worth $57,000 after buying an additional 1,600 shares during the last quarter. Sterling Capital Management LLC increased its position in Owens & Minor by 758.3% during the 4th quarter. Sterling Capital Management LLC now owns 2,060 shares of the company's stock valued at $27,000 after buying an additional 1,820 shares in the last quarter. Legal & General Group Plc increased its position in Owens & Minor by 0.9% during the 4th quarter. Legal & General Group Plc now owns 212,061 shares of the company's stock valued at $2,772,000 after buying an additional 1,991 shares in the last quarter. Finally, Tower Research Capital LLC TRC raised its stake in Owens & Minor by 11.6% in the fourth quarter. Tower Research Capital LLC TRC now owns 20,259 shares of the company's stock valued at $265,000 after buying an additional 2,112 shares during the last quarter. 98.04% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, major shareholder Coliseum Capital Management, L acquired 354,901 shares of Owens & Minor stock in a transaction on Monday, March 3rd. The stock was bought at an average cost of $9.19 per share, for a total transaction of $3,261,540.19. Following the completion of the transaction, the insider now owns 9,824,599 shares of the company's stock, valued at approximately $90,288,064.81. The trade was a 3.75 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Over the last three months, insiders have bought 2,718,412 shares of company stock valued at $24,495,308. Corporate insiders own 3.69% of the company's stock.

Owens & Minor Stock Performance

Shares of NYSE:OMI traded up $0.03 during midday trading on Friday, reaching $7.02. The company's stock had a trading volume of 1,798,096 shares, compared to its average volume of 1,121,481. The firm has a market capitalization of $542.33 million, a PE ratio of -10.80, a P/E/G ratio of 0.20 and a beta of 1.38. The stock has a fifty day moving average of $8.13 and a 200 day moving average of $10.79. Owens & Minor, Inc. has a twelve month low of $6.07 and a twelve month high of $21.02. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11.

Owens & Minor (NYSE:OMI - Get Free Report) last released its quarterly earnings data on Saturday, May 10th. The company reported $0.23 earnings per share for the quarter, beating analysts' consensus estimates of $0.20 by $0.03. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. During the same quarter last year, the company posted $0.19 earnings per share. Owens & Minor's revenue for the quarter was up .7% on a year-over-year basis. On average, equities analysts expect that Owens & Minor, Inc. will post 1.51 EPS for the current fiscal year.

Owens & Minor announced that its board has initiated a stock buyback program on Friday, February 28th that permits the company to repurchase $100.00 million in outstanding shares. This repurchase authorization permits the company to repurchase up to 13.6% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's management believes its stock is undervalued.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on OMI. Citigroup cut their price objective on shares of Owens & Minor from $13.00 to $11.00 and set a "buy" rating on the stock in a report on Thursday, April 17th. Robert W. Baird upped their price target on shares of Owens & Minor from $10.00 to $11.00 and gave the company a "neutral" rating in a research note on Monday, March 3rd. UBS Group lowered their price objective on shares of Owens & Minor from $25.00 to $13.00 and set a "buy" rating for the company in a research note on Thursday, February 13th. Finally, JPMorgan Chase & Co. cut their target price on Owens & Minor from $14.00 to $10.00 and set an "underweight" rating on the stock in a research report on Monday, March 10th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $12.50.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.